You are here:
22 February 2016
Meningitis A nearly eliminated in Africa through vaccination
Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.
10 November 2015
Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A
New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.
25 June 2015
Health in the Sahel region, together to improve immunisation programmes
The AFD, the Bill and Melinda Gates Foundation and Gavi signed an Initiative to increase coverage rates in six Sahel countries.
05 August 2014
Niger tackles its two biggest child killers with Gavi support
Life-saving pneumococcal and rotavirus vaccines are to be provided to all Niger’s children.
29 May 2013
Vaccines against cervical cancer and rubella to benefit health of women and girls
Two new vaccines that help protect against cervical cancer, measles and rubella spearhead the GAVI Alliance’s commitment to improving the health of girls and women.
28 May 2013
Voices from the Global Forum on Cervical Cancer Prevention
Over 400 Government leaders, policymakers, healthcare professionals, NGOs and corporate leaders gathered for the first-ever Global Forum on Cervical Cancer Prevention on 27 May.
14 May 2013
Kenya first country to protect girls against cervical cancer with GAVI support
Kenya becomes the first country to protect girls against cervical cancer with GAVI-supported human papillomavirus (HPV) vaccines.
08 May 2013
Millions of girls in developing countries to be protected against cervical cancer thanks to new HPV vaccine deals
Historic agreements show power of innovative public-private partnership
04 February 2013
GAVI funds vaccines to protect girls against cervical cancer
More than 180,000 girls in eight developing countries are set to receive protection against the leading cause of cervical cancer thanks to human papillomavirus (HPV) vaccines funded by the GAVI Alliance.
10 January 2013
GAVI recognised for effectiveness and focus on results
In its first ever Multilateral Organisation Performance Assessment Network (MOPAN) review the GAVI Alliance has been commended for its effectiveness in increasing access to immunisation and for its focus on results.
03 December 2012
100 millionth person receives lifesaving meningitis vaccine
A revolutionary meningitis vaccine will reach the 100 millionth person this week in a region of Africa that has been plagued by deadly epidemics for more than a century. The milestone will take place in northern Nigeria, part of Africa’s “meningitis belt’, where the country is conducting its second seasonal immunisation campaign against the disease.
05 October 2012
Useful information for anyone attending the Partners' Forum in Tanzania: Climate, Passports & Visas, Health, Safety, General behaviour in public, Currency, Tipping, Electricity, Shopping
04 October 2012
GAVI partners help protect 50 million young people from seasonal meningitis in Africa
Efforts to eliminate meningitis in 26 at-risk countries will take a major step forward over the next three months as 50 million people receive crucial vaccinations in seven African countries.
25 May 2012
Rwanda introduces new vaccine against a leading childhood killer
Rotavirus vaccines will protect children from severe and deadly diarrhoea.
21 February 2012
Q and A on Nigeria’s introduction of MenAfriVac
Interview with Muhammad Sani Adamu, Head of Accelerated Disease Control in Nigeria’s National Primary Health Care Development Agency, who played a key role in rolling out the new vaccine against meningitis A, MenAfriVac, to Nigeria’s northern states.
26 January 2012
Chad’s campaign against meningitis A
One of the first countries to introduce the new meningitis A vaccine (MenAfriVac), Chad ran an immunisation campaign with GAVI support in December 2011 to help eliminate the region’s devastating epidemics.
19 January 2012
GAVI works with Cameroon and Niger to recover misused funds
Following separate investigations into the misuse of GAVI funding in Cameroon and Niger, both Ministries of Health have cooperated fully and confirmed their commitment to take all necessary measures, including the reimbursement of misused funds.
27 September 2011
Accelerating Africa's access to rotavirus vaccine
Sudan's introduction of rotavirus vaccine earlier this year signalled the start of a wave of African countries ready to counter the world's leading cause of diarrhoeal deaths with GAVI support. In September, the Alliance approved funding for 12 more African countries to introduce the rotavirus vaccine.
17 July 2011
Milestone in preventing child deaths from diarrhoea in Africa
GAVI Alliance supports African introduction of rotavirus vaccines against the leading cause of severe infant diarrhoea.
10 June 2011
Developing countries make record demand for life-saving vaccines
A record 50 GAVI eligible countries have applied for vaccine funding from the GAVI Alliance during the organisation’s latest application round, reported GAVI officials today.
11 May 2011
GAVI commits US$ 100 million to fight meningitis A
The GAVI Alliance has committed US$ 100 million to help tackle meningitis A in Cameroon, Chad, and Nigeria, part of a strategy to save tens of thousands of lives in Africa with a new life-saving vaccine, MenAfriVac.
30 March 2011
GAVI Alliance steps up transparency on oversight of its cash programmes
To further increase transparency of the oversight of its cash-based support, the GAVI Alliance announced today that it will make public when it suspends a cash programme to investigate possible misuse of funds.
06 December 2010
New meningitis A vaccine introduced in Burkina Faso
GAVI supports mass vaccination campaign in “meningitis belt”.
Meningitis vaccine introduced in Africa's meningitis belt
For years and years, meningitis epidemics in the 25 countries of Africa's meningitis belt have caused death, disability and fear.
09 April 2009
GAVI partners mobilise to counter meningitis outbreaks
In an effort to save lives and contain the spread of meningitis, the GAVI Alliance has fast tracked a US$ 55 million contribution to establish a stockpile of meningococcal vaccines and pay for reactive campaigns in the highly endemic African “meningitis belt” countries.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2016
modal window here